Prime Medicine said it has gained FDA clearance for the first human trials of a prime editing therapy as the agency has approved an investigational new drug (IND) application for the company’s first ...
SHANGHAI, Nov. 5, 2025 /PRNewswire/ -- On November 6, 2025, Shanghai, China, CorrectSequence Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology company pioneering transformer Base ...
With a shared purpose, we can realize the true promise of CRISPR and improve healthcare, providing hope to more patients with ...
SAN FRANCISCO—Prime Medicine is on track to file the first IND/CTA application for human trials of a prime editing therapy to the FDA during the first half of this year, with the first clinical data ...
There's new hope this week for people who suffer from sickle cell disease. The Food and Drug Administration approved the first genetic treatments for the brutal blood disorder on Friday. The ...
KJ Muldoon, the first infant to undergo gene-editing therapy, has accomplished another first as a 1-year-old — his first steps KJ is walking at home ahead of Christmas after being hospitalized last ...
Researchers have successfully develop single-atom editing technology that maximizes drug efficacy. In pioneering drug development, the new technology that enables the easy and rapid editing of key ...
UBC researchers have created a topical CRISPR-based therapy that could offer a lasting cure for a range of skin disorders. Gene-editing tools like CRISPR have unlocked new treatments for previously ...
Former President Donald Trump announced yesterday he won't testify for a second time as planned in the New York civil fraud trial against him and his company. His lawyers previously said he would be ...
Rachael has a degree in Zoology from the University of Southampton, and specializes in animal behavior, evolution, palaeontology, and the environment.View full profile Rachael has a degree in Zoology ...
"I'm ecstatic. It's a blessing that they approved this therapy," said Victoria Gray, the first person in the U.S. to undergo CRISPR gene-editing for sickle cell, of the Food and Drug Administration's ...
The FDA approved the genetic therapies for anyone 12 and older suffering from the most severe form of sickle cell disease, a brutal blood disorder that has long been neglected by medical research. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results